| Meta Info | Content |
|---|---|
| Rating | Neutral (avoid chasing highs; wait for pullback or catalysts to materialize) |
| Target Price Range | RMB 11.3 – 13.3 (fair value range under base-case scenario) |
| Current Price | RMB 13.44 (closing price on 2026-10-28, CNY) |
| Margin of Safety | -15.9% ((base-case fair value lower bound 11.3 − current price) / current price, standardized methodology across the database) |
| Total Market Cap | Approx. RMB 61.97 billion (RMB 13.44 × total shares of 4.6108 billion, aggregated at A+H parity) |
| Time Horizon | 6–12 months |
| Core Valuation Anchor | PB ex-perpetuals 1.01x / PB incl.-perpetuals 0.83x; probability-weighted fair value approx. RMB 12.94, -3.7% vs. current price |
Everbright Securities is a mid-sized full-service broker with total assets of approx. RMB 350.5 billion (as of end-2026H1), ranking around 13th in the industry. Its wealth management cluster contributes roughly 60% of gross profit, and earnings are highly correlated with market trading activity. In 2026H1, net profit attributable to shareholders was RMB 2.229 billion (+32.45%), but growth lagged listed brokers overall (43 firms +48.7%); weighted ROE has remained below 6.9% for four consecutive years, margin financing & securities lending market share has declined consecutively to 2.02%, and investment banking revenue has fallen for three and a half years straight — endogenous competitiveness indicators are broadly weak. The current price of RMB 13.44 corresponds to a PB ex-perpetuals of approx. 1.01x; solving backward via the Gordon relationship implies a market expectation of "sustainable ROE repair to 8.5–10.5%," whereas the company's actual ROE is only 5.6–6.6%; trading activity cooled in 2026Q3 (average daily stock+fund turnover down approx. -14.5% QoQ, margin balance retreating from its RMB 3.02 trillion peak to approx. RMB 2.43 trillion), which is validating from the opposite side how difficult it will be to realize this expectation. The report's fair value ranges across three scenarios: bear RMB 10.0–11.3 (27%) / base RMB 11.3–13.3 (48%) / bull RMB 15.3–18.0 (25%), probability-weighted at approx. RMB 12.94. The current price sits above the upper bound of the base-case range; valuation is "moderately overvalued" rather than a bubble — book net assets, the 30%+ dividend commitment, and the largely provisioned and cleared MPS risk provide downside support, but upside requires trading activity to stabilize or external catalysts such as Central Huijin-system consolidation to materialize. We assign a Neutral rating and advise against chasing highs; reassess after the share price falls below RMB 12 (PB ex-perpetuals ≤0.9x) or after trading/governance catalysts emerge.
Opportunity Definition (one sentence): A "wait-and-see" target with zero margin of safety from the current price — valuation has already prepaid much of the ROE repair and consolidation option; investable opportunity requires waiting for the price to fall below RMB 12, or for one of three catalysts to materialize: trading activity stabilization, appointment of a new president, or substantive signals of Central Huijin-system consolidation.
The current price of RMB 13.44 = PB ex-perpetuals 1.01x (2nd percentile over the past 5 years, 8th percentile over the past 10 years). Solving backward via the Gordon relationship (PB=(ROE−g)/(r−g), g=3%) implies a sustainable ROE of approx. 8.5–10.5% (r at 8.5–10.5%; approx. 9.5% when r=9.5%); yet the company's FY2025 weighted ROE was only 5.58%, annualized approx. 6.6% in 26H1, and even the previous cycle's peak (2021) did not exceed 7.5% — a gap of approx. 1.9–4 percentage points versus the implied value. Two methodological notes: first, the low PB percentile is mainly a sector-wide phenomenon for brokers (the sector overall is at a low percentile over the past decade) rather than Everbright being individually "cheap"; second, this premium comprises both "ROE repair expectations" and the "consolidation theme option," and cannot be read entirely as an earnings expectation. The base-case fair value range of RMB 11.3–13.3 corresponds to a PB ex-perpetuals of 0.85–1.0x — anchored to the 1-year PB median (approx. 1.16x) and peer PB-ROE positioning (companies with ROE of 6–6.5% should trade at a 15–25% discount to the peer median); the current price is approx. 1% above the upper bound of this range and approx. 8.5% above the midpoint.
This report's counter-scenario: if the brokers' cost of equity drifts below 8.5% in a low-rate environment, or if the trading activity center becomes durably entrenched above ADT of RMB 2.5 trillion, the gap between implied expectations and reality will narrow, and the "expensive" conclusion would need revisiting — this is why the confidence level for this item is set at 0.65 rather than higher.
Brokerage + net interest income accounted for approx. 60% of 2026H1 revenue; the main driver of H1's +32.45% net profit growth was the surge in market trading volume (ADT of approx. RMB 2.45 trillion since the start of 2026, sharply up YoY) rather than market share gains. Over the same period, 43 listed brokers posted net profit +48.7% (50-firm basis +48.66%; mean includes outliers, median undisclosed) — Everbright clearly underperformed. Q3 trading cooling has already occurred: stock+fund ADT down approx. -14.5% QoQ (an alternative stock-only estimate suggests approx. -22%; methodological discrepancy noted), September ADT of RMB 1.83 trillion was the year's lowest, the margin balance retreated approx. RMB 0.57 trillion from its peak, and September new accounts fell -34.9% YoY. The arithmetic of the slowdown is clear: 2025Q3 standalone net profit of RMB 995 million (+65.88%) is a high base, and Q4 also faces the RMB 1.046 billion standalone base following 2025's "924 rally"; consensus EPS of RMB 0.965 implies H2 net profit of approx. RMB 2.22 billion (+8.8% YoY) — if Q3 standalone comes in at only RMB 850 million (-14.6% YoY), Q4 would need RMB 1.37 billion (+31% YoY) to hit the target — a demanding hurdle. Offsetting factors to note: the company's margin financing balance is still growing in absolute terms (H1 financing balance +12.4% vs. start of year, collateral coverage ratio 284.83%); part of the share decline reflects expansion of the market-wide denominator and does not necessarily indicate deteriorating competitiveness.
Three facts support the valuation: ① PB incl.-perpetuals of 0.83x, below the comparable peer median (rough estimate approx. 0.86x; sample not verified firm-by-firm); ② three consecutive years of delivering on the dividend commitment — annual payout ratios of 30.26%/30.02%/35.10% (2023–2025), 2026 interim dividend of RMB 0.17 per share (total RMB 784 million, payout ratio approx. 35.2%) to be paid on December 16, TTM dividend yield approx. 2.1%; ③ MPS risk provisions largely cleared — MPS-related provision balance down to RMB 466 million (total consolidated provisions RMB 514 million), with multiple lawsuits at final judgment entering enforcement. But the quality of this "floor" deserves a discount: financial investment assets of RMB 128.185 billion are about 2x net assets ex-perpetuals (RMB 61.47 billion), and 2026H1 net loss after tax in other comprehensive income was RMB 496 million — in a sharp market decline scenario, BPS is a moving floor rather than a hard one; the RMB 2.64 billion enforcement settlement is being paid in installments (through approx. September 2027), and in April 2026 the English High Court dismissed the approx. RMB 4.2 billion recovery claim against MPS's original seller, so "cleared" should be understood as "provision-cleared with cash installments still in transit"; also, the H-shares of the same-equity class trade at only RMB 5.46 (a 59.4% discount, PB incl.-perpetuals of approx. 0.34x) — international capital's pricing of the same book value is a persistent reference pressure.
At the factual level: President Liu Qiuming resigned on 2026-09-18 due to term expiry (the announcement confirmed no disagreement with the board; media reports indicated his original term ran to May 2027, with both "normal transition" and "early departure" interpretations coexisting — the announcement's wording is "due to term reasons"); Chairman Zhao Ling has been acting as president and legal representative since 9-22. The year also saw 3 other director/senior management changes (of varying natures: additional appointments, retirement at statutory age, work reassignment) and a mid-2026 warning letter from the Shanghai CSRC (overseas subsidiary decision-making procedures, research report conflicts of interest). At the company level there are no buybacks (e-interactive responses only "studying the feasibility of buybacks," while peers such as Hongta, Sinolink, and Zhongtai have already launched cancellation-type buybacks) and no insider buying records; the only shareholder-return tool currently is cash dividends. Meanwhile, the company has disclosed a "Market Value Management Measures" document, and key management compensation fell 22.8% in 2025 (media basis, to be verified). Transition-period uncertainty is one source of the discount, but the -3.6% share price decline since 9-18 is mixed in with the sector drawdown, making it difficult to isolate the independent suppression effect — this item is graded as an "uncertainty factor" rather than a "confirmed suppression."
Supply-side consolidation is the industry's biggest structural variable: after the Guotai Haitong merger (2025-04) and CICC's absorption of Dongxing + Xinda (delivery completed 2026-10-26), the capital gap between top-tier and mid-tier firms has widened further — CITIC Securities' total assets broke RMB 2.4 trillion by end-2026H1, with Everbright's RMB 350.5 billion at roughly 1/6.9 of that. Everbright did not participate in this round of consolidation, with weakening shares in margin financing/investment banking/asset management, placing it in a passive position in the industry's evolution toward "3–5 aircraft-carrier-class institutions." Central Huijin-system consolidation is "in progress": SWS Research (2025-11) listed 6 remaining brokers in the Huijin system (CICC, China Galaxy, SWS, CSC Financial, Everbright, Great Wall Guorui), with Everbright among them; its A+H dual listing and the major shareholder's high ownership concentration (Everbright Group + China Everbright Limited combined approx. 45.9%) reduce transaction execution difficulty. However, as of 2026-10-28, there has been no public statement or consolidation indication at the company, Everbright Group, or Central Huijin level, and the market-speculated "merger with SWS" is pure conjecture. This report subjectively assigns this option a probability of approx. 10–15% (a scenario assignment without event-base-rate derivation), counting it only as a source of jump in the bull scenario (the tail above the RMB 15.3–18.0 range), and excluding it from base-case valuation.
Everbright Securities is a financial institution (brokerage); industrial-sector metrics such as free cash flow, net debt/EBITDA, and cash and equivalents are structurally inapplicable and have been removed from this table, replaced by regulatory capital and risk-control indicators.
| Metric | FY2023 | FY2024 | FY2025 | 2026H1 (latest period) |
|---|---|---|---|---|
| Operating revenue (RMB 100mn) | 100.31 | 95.98 (-4.32%) | 108.52 (+13.06%) | 60.56 (+18.17%) |
| Net profit attributable to shareholders (RMB 100mn) | 42.71 | 30.58 (-28.39%) | 37.24 (+21.77%) | 22.29 (+32.45%) |
| Ex-non-recurring net profit (RMB 100mn) | 18.72 | 30.08 (+60.66%) | 35.57 (+18.24%) | 20.62 (+33.64%) |
| Weighted ROE (%) | 6.91 | 4.58 | 5.58 | 3.28 (non-annualized) |
| Net margin (attributable/revenue, %) | 42.6 | 31.9 | 34.3 | 36.8 |
| Total assets (RMB 100mn, period-end) | 2,596.04 | 2,929.59 | 3,181.14 | 3,504.82 (+10.18% vs. start of year) |
| Net assets attributable to shareholders (RMB 100mn, incl. perpetual bonds, period-end) | 670.89 | 683.90 | 719.24 | 744.71 (+3.54% vs. start of year) |
| Net assets per share (RMB, incl. perpetuals) | 14.55 | 14.83 | 15.60 | 16.15 (13.33 ex-perpetuals) |
| Net capital (RMB 100mn, parent) | — | — | 460.36 | 492.11 |
| Risk coverage ratio (%, ≥100) | — | 344.20 | 322.31 | 323.36 |
| Liquidity coverage ratio LCR (%, ≥100) | 232.90 | 216.14 | 210.39 | 146.03 (-64.4pp over six months) |
| Net stable funding ratio NSFR (%, ≥100) | — | 189.46 | 167.43 | 149.42 |
| Margin financing & securities lending balance (RMB 100mn) | 343.5 | 412.93 | 543.86 | 610.07 (market share approx. 2.02%) |
| Cash payout ratio (%) | 30.26 | 30.02 | 35.10 | 35.16 (2026 interim) |
Reasons for Metric Changes (items with YoY ≥ ±20%, all with management commentary):
2026H1 revenue RMB 6.056 billion (+18.17%), net profit attributable to parent RMB 2.229 billion (+32.45%), recurring net profit RMB 2.062 billion (+33.64%); of which Q1 net profit attributable to parent RMB 1.166 billion (+42.34%), Q2 single quarter RMB 1.063 billion (approx. +23.1% YoY) — momentum slowed sequentially but the absolute level remains high. Revenue diverged sharply across the four lines: brokerage RMB 2.373 billion (+39.32%) and interest income RMB 1.270 billion (+17.29%) benefited from the surge in trading volume; proprietary trading RMB 1.435 billion (approx. +12%; investment income RMB 1.771 billion + fair value change of -RMB 0.336 billion) was steady; investment banking RMB 0.274 billion (-24.69%) declined for the third consecutive half-year period, with the corporate financing cluster's revenue -25% and cluster gross margin falling to 21% (-17pp); asset management RMB 0.451 billion (+5.75%) grew slowly. The institutional client cluster (research/custody/market-making) +48% was a structural bright spot, with custody scale +80.6%.
For comparison: listed brokers' 2026H1 aggregate revenue +44.8% and net profit attributable to parent +48.7% — Everbright underperformed the industry by approx. 16 percentage points during a period of high industry growth, consistent with its competitive position in margin financing market share (2.02%, continuously declining) and equity underwriting ranking (32nd). Against sell-side consensus (FY2026E EPS RMB 0.965, implying net profit attributable to parent of approx. RMB 4.8 billion): H1 completion at 46%, combined with Q3 trading cooling and the high 2025Q4 base (single quarter RMB 1.046 billion), meeting full-year targets requires H2 YoY growth of +23%, and the difficulty of achieving this is rising — this report's own estimate of FY2026E net profit attributable to parent is RMB 4.1-4.4 billion (ordinary-share EPS RMB 0.81-0.88). Management provided no quantitative guidance, making it impossible to evaluate "beat/miss" against guidance; given the stock's -24.5% year-to-date drawdown, the market has already priced in much of "underperformance vs peers + trading cooling." The Q3 report due 10-30 (Q3 single-quarter net profit attributable to parent ≥RMB 0.995 billion as the YoY turn-positive line, ≥RMB 0.717 billion as the +10% cumulative line) is the nearest verification point.
Business model in brief: a hybrid mid-size broker — revenue is dominated by the wealth management cluster (FY2025: 55%; 26H1: 57%); brokerage commissions + margin interest spreads + fund distribution/advisory form the "market beta engine"; intermediary income (fees + interest) accounts for approx. 75% of total, proprietary investment approx. 22.8% — a structure of "light-capital income as the mainstay, heavy-capital assets a large share." Revenue recurring-ness depends on the trading volume center rather than contracts — commission rates are on a secular decline (0.0192% → 0.0158%), the company has no pricing power, and "recurring" nature lies in its client base (7.504 million clients, RMB 1.71 trillion in client assets) rather than fee rates. The OCF/FCF/ROIC/capex framework is structurally inapplicable to this business model; earnings quality is assessed on a broker-specific basis:
Word-deed consistency: partially fulfilled, leaning pragmatic and conservative. ① Dividend commitment: "cash dividend ratio consistently maintained above 30%" — actual 30.26%/30.02%/35.10% for FY2023/24/25; 2026 interim dividend planned at RMB 0.17/share — fulfilled; ② FY2024 annual report statement that "margin financing growth outpaced the market" — in 2025 the company's margin balance +31.71% vs market +36.26%; 2026H1 +12.17% vs +18.88% — underperformed for two consecutive periods, and the FY2025 annual report no longer makes this claim (retracted rather than explained); ③ FY2025 qualitative goals (client acquisition and revenue growth, endogenous development) — revenue +13.06%, attributable profit +21.77%; direction fulfilled but no quantitative commitment to verify.
Shareholder friendliness: neutral-to-friendly (dividends fulfilled) + deductions for capital instrument expansion. Cumulative cash dividends over the past three years RMB 3.518 billion (approx. 95% of average annual ordinary-share net profit, regulatory basis); interim dividends for the third consecutive year; no ordinary-share refinancing dilution. Deductions: no buyback (compared with peers such as Hongta, Sinolink and Zhongtai that have launched cancellation-type buybacks, the company has only "studied feasibility"); perpetual bonds expanded 9.5 → 11.0 → 13.0 billion over three years, with interest of approx. RMB 0.37 billion per year senior to ordinary shareholders.
Risk signals: chairman acting as president after the president's resignation; selection of a new president may span into next year (governance transition); 3 director/senior-management changes within 2026; a warning letter from the Shanghai CSRC bureau in mid-2026 (overseas subsidiary decision procedures, research report conflicts of interest), which will count as a deduction in the 2026 classification rating; highly templated investor-platform replies; investors repeatedly questioning the stock's long-term underperformance vs the industry.
The company discloses six clusters (FY2025 basis, 26H1 in parentheses):
| Cluster | Revenue share | Cluster gross margin | YoY | One-line business logic |
|---|---|---|---|---|
| Wealth management | 55% (57%) | 64% (69%) | +25% (+30%) | Brokerage commissions + margin spreads + distribution/advisory; market beta engine |
| Investment & trading (proprietary) | 12% (10%) | 93% | +18% (-3%) | Equity + fixed income absolute return; low capital efficiency but high margin |
| Asset management | 11% (10%) | 34% (35%) | +2% (+2%) | Everbright AM + Everbright Prudential (55%); AUM continuously shrinking |
| Institutional clients | 10% (14%) | 66% (79%) | +1% (+48%) | Research/custody/market-making/derivatives; custody +80.6% in 26H1 |
| Corporate finance (IB) | 8% (5%) | 45% (21%) | +2% (-25%) | Weak equity underwriting (32nd) + debt underwriting (11th) + overseas |
| Equity investment | -RMB 0.137 billion (-RMB 0.219 billion) | Negative | Persistent losses | Everbright Capital et al.; MPS legacy + fair value drag |
Profit drivers: estimated by gross profit pool contribution ("revenue share × gross margin") — wealth management approx. 58%, investment & trading approx. 19%, institutional clients approx. 11%, asset management approx. 6%, corporate finance approx. 6%. Wealth management is both the revenue and profit mainstay, meaning earnings sensitivity to the trading volume center is higher than for peers with more balanced businesses; investment & trading contributes 19% of gross profit on 12% of revenue — the second profit source but already negative growth in 26H1. Gross margin structure varies enormously (93% vs 21%): investment & trading is a spread business on proprietary financial assets with almost no direct costs; corporate finance is labor-intensive with intense underwriting fee competition — its gross margin plunged 17pp to 21% in 26H1, reflecting cost rigidity during the equity financing downturn.
Accounting red flags (by severity):
Inter-period consistency:
Current market data (close 2026-10-28): price RMB 13.44, market cap RMB 61.97 billion, currency CNY. PE(TTM) 14.51x (1st percentile of the past 5 years — low PE percentile reflects earnings at an improved high level; reference only, not a cheap/expensive signal); PB(LF) ex-perpetuals 1.01x (percentiles 0%/0%/2% over past 1/3/5 years; 5-year range 0.97-1.70, median 1.30; 10-year range 0.80-2.69, median 1.31); including perpetuals 0.83x. Peer benchmarking (PB is a rough estimate; ROE on FY2025 weighted or 26H1 half-year/annualized basis):
| Company | PB(LF) | ROE | 2026H1 attributable profit growth | Positioning |
|---|---|---|---|---|
| CITIC Securities | ~1.15 | 9.81% (26H1 half-year 6.96%) | +50.0% | All-round leader |
| China Merchants Securities | ~1.00 | 9.21% (26H1 half-year 7.51%) | +104.9% | Group synergies + institutional |
| GF Securities | ~0.86 | 26H1 half-year 8.1% | +80.1% | Public fund asset management powerhouse |
| Guotai Haitong | ~0.85 | 26H1 annualized approx. 12.4% | +97.6% (low base) | Merger template; largest by scale |
| Everbright Securities | 0.83 (1.01 ex-perpetuals) | 5.58% | +32.5% | Mid-size; wealth-management-led |
| Huatai Securities | ~0.76 | 8.22% (26H1 half-year 5.53%) | +54.9% | Tech-driven wealth management |
What expectations are already priced in: solving back from the current ex-perpetual PB of 1.01x implies a sustainable ROE of approx. 8.5-10.5% (sensitive to discount rate: 8.54% at r=8.5%, 10.56% at r=10.5%) — i.e., the market requires Everbright to lift ROE to 80-90% of the listed-broker average, while reality is four consecutive years below 6.9%. The corresponding trading assumptions are an ADT center persistently at RMB 2.5-3 trillion and margin balance above RMB 2.8 trillion. Q3 data (ADT down QoQ, margin balance easing to RMB 2.43 trillion, new accounts at lows) point the other way. Note that this premium mixes in an integration-theme option (see Thesis C5); single-variable back-solving slightly overstates the "earnings expectations" component; the H-share pricing at 0.34x PB incl. perpetuals represents the opposite view assigning almost no value to that option.
Three-layer value (EPV): asset value (floor) = ex-perpetual BPS RMB 13.33 (incl. perpetuals RMB 16.15) — but in a sharp selloff this is a moving floor (financial investments approx. 2x ex-perpetual net assets; H1 OCI after tax -RMB 0.496 billion); zero-growth EPV = normalized EPS RMB 0.83 (normalized ROE 6.25% × ex-perpetual BPS 13.33, taking the midpoint of the 2022-2025 actual average of approx. 5.4% and the 26H1 annualized 6.6%) ÷ cost of equity 9.5% ≈ RMB 8.7/share (range 6.98-9.63, corresponding to ROE 5.5-6.5% and r 9-10.5%); the current price is approx. 53% above EPV, with a residual of approx. RMB 4.7 (approx. 35% of price) entirely growth options of "rising trading center + ROE repair + integration option" — that option is a non-trivial share (approx. one third); the market is not "paying only for zero growth." DDM cross-check (DPS RMB 0.27, g=4.2%, r=9.5%) gives only approx. RMB 2.9, flagging the downside risk of retained earnings destroying value when ROE < cost of capital — the true EPV anchor leans toward the lower end of the range. The current price is mainly supported by the asset-value layer (1.01x BPS).
Three scenarios and odds (figures consistent with the thesis's structured scenarios):
| Scenario | Probability | Fair range | vs current | Key drivers |
|---|---|---|---|---|
| Bear | 27% | RMB 10.0-11.3 | -25.6%~-15.9% | ADT falls to RMB 1.5 trillion / margin RMB 2 trillion; ROE reverts to approx. 4.5%; PB 0.75-0.85x ex-perpetuals (anchored to the 10-year PB bottom range and the actual 2024 ROE level) |
| Base | 48% | RMB 11.3-13.3 | -15.9%~-1.0% | ADT center RMB 2.2-2.6 trillion, margin RMB 2.4-2.8 trillion; ROE 6.0-6.5%; PB 0.85-1.0x ex-perpetuals (anchored to the discount vs the 1-year median of 1.16x and peer PB-ROE positioning; not self-validated by the current multiple) |
| Bull | 25% | RMB 15.3-18.0 | +13.8%~+33.9% | Trading returns to RMB 3 trillion+ with record margin balances, or substantive Huijin-group integration lands; ROE repaired to 8.5-9.5%; PB 1.15-1.35x (anchored to the lower part of the 3-year 75-90th percentiles; an "acquired" event premium could pierce the upper bound) |
Probability-weighted fair value approx. RMB 12.94, -3.7% vs current; odds are asymmetric: bear-case midpoint -20.8% vs bull-case midpoint +23.9%. External coordinates: no individual sell-side target prices (coverage limited to 2 Buy-rated samples, no sell ratings); on the industry side, CITIC Securities Research (2026-08-31) expects 2026 industry profit +14% and sector valuation below the 10th percentile of the past decade — "attractive risk-reward." That judgment is sector-level; extrapolating to the individual stock assumes share stabilization, in tension with Everbright's weakening share, so it is not adopted as the stock anchor.
Earnings forecast and three-way comparison: this report's FY2026E revenue RMB 11.4-11.8 billion (+5%~+9%), attributable profit RMB 4.1-4.4 billion (+10%~+18%) — H1 delivered RMB 2.229 billion, H2 assumed RMB 1.9-2.1 billion (Q3 slight YoY growth, Q4 flat against a high base); FY2027E attributable profit RMB 4.3-4.7 billion. Management guidance: no quantitative guidance (qualitative only); sell-side consensus: EPS RMB 0.965 (attributable approx. RMB 4.8 billion; 2-sample; revised down 6.8% within 90 days; single-sample FY2027E EPS RMB 0.94 implying negative growth). This report's forecast is approx. 8-15% below consensus; the divergence lies in the Q4 trading path.
Conclusion: moderately overvalued (judgment: overvalued). Target price range RMB 11.3-13.3 (base-case fair value), margin of safety -15.9% (unified database basis: base-case fair value lower bound vs current price). Assess quality and price separately: quality — a mid-size broker with weak competitive metrics and ROE below the cost of capital; price — ex-perpetual PB already above the level supported by the peer PB-ROE relationship, with implied expectations overshooting by approx. 2-4 ROE percentage points. The 0.83x incl.-perpetuals valuation and 2.1% dividend yield provide downside cushion, hence not judged a "bubble."
1. Industry Size: China's securities industry is a capital-market intermediary sector composed of 150 licensed brokerages. By scale (official data from the Securities Association of China): at end-2025, industry total assets were RMB 14.83 trillion, net assets RMB 3.34 trillion, net capital RMB 2.44 trillion; by 2026-06-30, total assets rose to RMB 17.23 trillion, net assets RMB 3.48 trillion, net capital RMB 2.59 trillion, client transaction settlement funds RMB 4.45 trillion, and assets under entrusted management RMB 10.23 trillion. Revenue and profit: full-year 2025 industry revenue was RMB 541.171 billion and net profit RMB 219.439 billion (128 firms profitable, 85.3% profitability rate); H1 2026 revenue RMB 329.810 billion and net profit RMB 138.664 billion (approximately +31%/+23% YoY, per KPMG compiled figures). Growth is anchored on two long-term variables: the share of direct financing (29.2% in 2020 → ~33% in 2026Q3, still 20–30 percentage points below Japan) and the migration of household wealth into equities (real estate + deposits account for 81% of household assets vs. 35% in the US, per Kaiyuan Securities estimates; its forecast of a RMB 150 trillion wealth management market by 2030 at ~12% CAGR is an aggregated secondary citation, pending verification). In 2026H1, listed brokerages (43 firms) posted revenue of RMB 364.71 billion, +44.8%, and net profit attributable to parent of RMB 155.37 billion, +48.7% — a strength of prosperity rarely seen historically.
2. Value Chain and Value Distribution: The upstream consists of capital and funding providers — client margin deposits (RMB 4.45 trillion), low-cost bond financing (listed brokerages issued RMB 1.02 trillion in bonds in the first three quarters of 2025, with coupon rates of 1.52%–3.45%), and central bank facilities (SFISF swap facility, with a combined quota of RMB 800 billion together with the share repurchase/increase relending facility); the midstream is the brokerages themselves, whose revenue mix has shifted from "brokerage-dominant" (49% of revenue in 2013) to "proprietary-trading-dominant" (in 2026H1, proprietary investment accounted for 34.3% > brokerage 31.6% > interest income 12.3% > investment banking 5.6% > asset management 3.7%); the downstream comprises retail investors, institutional investors, financing enterprises, and fund managers, with the wealth management side simultaneously being siphoned by banks, internet platforms (East Money), and direct sales by public funds. The key point on value distribution: capital-intensive businesses (proprietary trading + credit) account for roughly 46–50% of revenue, and profits increasingly depend on "capital size × leverage × investment capability" rather than license-based channels — this is precisely the industrial logic behind head-end concentration and consolidation via M&A. Brokerage commission rates are on a structural downtrend (Guosen Securities estimate: 1.92 bps → 1.58 bps, 2024Q3 → first three quarters of 2025), and the industry compensates with volume (two-way stock/fund turnover in the first three quarters of 2025 +47.2%, with brokerage net revenue still up +74.6%).
3. Supply-Demand and Competitive Landscape: On the demand side, 2025–2026 consistently exceeded expectations — ADT rose from ~RMB 0.9–1.0 trillion in 2024 → RMB 1.73 trillion in 2025 (annual turnover of RMB 419.86 trillion, an all-time high) → ~RMB 2.45 trillion since early 2026 (single-day peak of RMB 3.6 trillion in July); margin financing balances: RMB 1.86 → 2.54 → 3.02 trillion (first crossing of RMB 3 trillion in June 2026) → falling back to ~RMB 2.43–2.46 trillion by October; IPO proceeds in the first three quarters of 2025 were RMB 77.3 billion (+61.5%), and Hong Kong IPO fundraising was HKD 285.8 billion (+225%). On the supply side, licenses have been locked at 150 firms for years with no new entrants; capacity equals capital: CITIC's net capital ~RMB 181 billion, Guotai Haitong ~RMB 226 billion — head firms overwhelmingly dominant. Industry restructuring proceeds through M&A — 15 deals involving 26 brokerages since 2024. Concentration (total assets including client funds, as of end-2026H1): CR5 40.86%, CR10 60.43%; by revenue, the top ten brokerages account for 75%+ of listed brokerages' revenue and 81%+ of net profit; business-line concentration is even higher: equity underwriting CR5 73.58%, asset management CR3 56.05%. Entry barriers are fourfold: licenses, capital, client stickiness, and technology ecosystems; competition is white-hot: commission rates at new lows, margin lending rates pushed below 3%. Current supply-demand balance: prosperity falling back from high levels — 2026Q3 turnover down -14.5% QoQ, margin balance down ~RMB 570 billion from its peak, leading firms posting negative single-quarter profit growth (CITIC Q3 -20.2%), and head-end M&A completions intensifying the exit of tail firms.
4. Cycle and Regulation: The industry is in a "pullback phase following epic-level prosperity" — after turnover/margin balances/ROE all hit or approached historical highs, A-shares hit an 11-year high in May 2026, margin balances peaked at RMB 3 trillion, followed by mild deleveraging from July to October; sector share prices have already undergone deep drawdowns ahead of fundamentals (YTD: Everbright -24.5%, Huatai -29.4%, CITIC -15.2%). Leading indicators: average daily turnover (whether it can hold at RMB 1.7–1.8 trillion), margin balance and financing purchases as a share of turnover (currently ~7.85%, far below the near-18% peak in 2015 — leverage crowding not yet extreme), IPO pipeline of accepted applications (322 firms in the first three quarters of 2025, +1.24x YoY), and monthly new account openings (1.9119 million in September, a YTD low — a clear signal of cooling retail momentum). The regulatory direction is broadly favorable with structural headwinds coexisting: investment-side reforms and the new "Nine National Guidelines" (2024-09) encourage head-end M&A and channel long-term capital into markets; the "Six M&A Guidelines" plus new classification evaluation rules catalyze consolidation; SFISF (first tranche RMB 500 billion + share repurchase/increase relending RMB 300 billion, combined into an RMB 800 billion quota in 2025-05) and new risk control indicator rules (lower risk capital reserve requirements for CSI 300 constituents, 90% capital charge for market-making) relax balance-sheet expansion and equity allocation; the three-phase public fund fee reform (management/custody fees → transaction commissions → sales fee rates effective 2026-01, annual concession of ~RMB 30 billion, cumulative over RMB 50 billion) systematically compresses light-capital fee rates — favoring head firms with capital and integration capabilities, unfavorable to mid-sized brokerages dependent on channel fees.
5. Peer Benchmarking Table (see Chapter 10 valuation peer table): the six-firm cross-section shows a clear PB-ROE pricing ladder — CITIC (1.15x/9.81%) and CMB (1.00x/9.21%) enjoy premiums on high ROE; Huatai (0.76x/8.22%) is contested as undervalued for its tech-driven wealth management efficiency; Everbright (0.83x including perpetuals/5.58%), with the lowest ROE, sits at the bottom of the ladder. Everbright's core gap lies in "capital productivity": revenue is only 1/8.2 of CITIC's, ROE trails head firms by 3–8 percentage points, and its 2026H1 growth (+32.5%) was below all five benchmarked peers.
6. Company Positioning within the Industry: Second-tier mid-sized full-service brokerage with a "follower" positioning. By scale: total assets of RMB 318.1 billion (end-2025), roughly 2.1% of the industry and ~13th among listed brokerages (total assets ~1/7.9 of Guotai Haitong's, 1/6.9 of CITIC's). By business line (2025 annual report/association data): brokerage revenue ~13th (2.7% of listed brokerages' total brokerage revenue, share roughly flat with a slight uptick), bond underwriting 11th (RMB 415.5 billion, the biggest highlight), equity underwriting 32nd (RMB 1.71 billion, a clear weakness), asset management revenue ~10th but Everbright Asset Management's AUM shrinking consecutively (declining share), margin financing market share 2.21% → 2.02% (consecutive declines). Overall judgment on share trends: channel-type business shares stabilizing; capital-type and investment banking shares under pressure. Sources of moat: Everbright Group synergy (cross-selling across the group's full financial licenses) + full licensing + Shanghai-based client foundation; under the double squeeze of the head-end M&A wave and declining fee rates, the company lacks capital scale and strong shareholder business synergy (relative to the China Merchants group and CITIC group); if industry consolidation deepens toward the Huijin group, there is speculative inorganic upside, but no public plan exists (see Thesis C5). Note on data: the company's annual report claims improved rankings in certain business lines (e.g., net commission income ranking up 1 place), which is not contradictory to third-party overall rankings (~13th) — the former uses narrower sub-metric definitions.
The industry's "decisive variable" for brokers lies not in products or channels, but in the product of three variables: turnover center × market share × capital leverage. A generic financial framework would miss the following defining dimensions:
① Revenue-Turnover Sensitivity: Brokerage (39.3% of revenue in 26H1) + margin interest (21.0%) together account for roughly 60% of revenue, directly tied to ADT and margin balances. This report estimates elasticity: each 10% decline in ADT reduces annualized brokerage net revenue by ~RMB 520 million, about 12% of annualized net profit attributable to parent; under the extreme stress scenario (ADT RMB 1.5 trillion, margin balance RMB 2 trillion, index down another 15%), brokerage loses -RMB 820 million, interest -RMB 760 million, proprietary equity exposure losses RMB 0.9–1.6 billion, totaling ~-RMB 2.57 billion after tax, with net profit attributable falling to ~RMB 1.89 billion (-57.6%) and ROE to ~2.4% — corresponding to a bear-case PB of 0.75–0.85x ex-perpetuals and a share price of RMB 10.0–11.3. Conversely, if ADT recovers 17% to RMB 1.85 trillion and margin balance rebounds to RMB 2.7 trillion, net profit elasticity is roughly +15–20% — the "trade on volume" essence of brokerage stocks is amplified at Everbright (higher wealth management share than peers).
② Commission Rates and Fee Reform: Industry commission rate is at 1.58 bps and still trending down; the three-phase public fund fee reform (sales fee rates effective 2026-01) pressures distribution income and the earnings of affiliated fund companies. Everbright's hedge is buy-side advisory (2025 advisory revenue +157%, distribution +32.3%) and the third-pillar pension business (personal pension fund distribution AUM +58% vs. end-2025), but the current scale contributes <2% to profit — fee declines are a certainty; hedging is a slow variable.
③ Proprietary Investment: Second Profit Engine and Source of Volatility: Financial investments of RMB 128.185 billion (end-26H1) ≈ 2x net assets ex-perpetuals; structurally, FVOCI assets account for 40.8%, and other equity instrument investments (high-dividend OCI holdings) rose +160.9% in six months to RMB 12.1 billion — an industry-wide allocation of "avoiding the P&L, thickening net assets." Investment yield: FY2024 2.00% → FY2025 1.88% → annualized 2.27% in 26H1 — absolute-return-oriented but capital-inefficient; fair value changes have been consecutively negative (FY2025 -RMB 382 million, 26H1 -RMB 336 million), and OCI in 26H1 was -RMB 496 million after tax — the cost of stable headline net profit is net asset volatility; BPS is a dynamic floor.
④ Regulatory Capital and Leverage Constraints: Net capital RMB 49.211 billion, risk coverage ratio 323.36% (regulatory line 100%) — a thick capital buffer; but LCR fell 64.4pp over six months to 146.03%, and NSFR 149.42% (warning line 120%), with balance-sheet expansion (financing outlays + trading financial assets) outpacing stable funding replenishment — trending toward consuming the liquidity buffer; apparent leverage 4.8x, ~2.9x ex-client funds, below international investment banks; room for further leverage is constrained by risk control indicators, not by willingness. RMB 13 billion of perpetual bonds are "quasi-preferred-share" capital instruments: they supplement net capital but ~RMB 370 million in annual interest takes priority over common shareholders.
⑤ A/H Dual Pricing: H shares at HKD 6.42 ≈ RMB 5.46, a 59.4% discount to A shares, PB including perpetuals of only 0.34x — a huge rift between two pricings of the same asset, which is both evidence that A shares carry an "integration/liquidity premium" and a vote of no confidence from international capital in the sustainability of mid-sized Chinese brokerages' ROE; A/H premium convergence has historically come via A-share declines rather than H-share rallies — a persistent reference pressure on A-share valuation.
Overall Rating: Neutral, confidence 0.55, time horizon 6–12 months. Everbright Securities is a mid-sized brokerage with "high β, weak α": it underperforms when industry prosperity is high and its earnings elasticity turns downward when turnover recedes (brokerage + interest account for 60% of revenue); long-term ROE below the cost of capital dictates a valuation center below the historical median PB. The current price of RMB 13.44 already prices in most expectations of ROE recovery and the integration option (the growth option accounts for ~35% of the current price); the probability-weighted fair value of RMB 12.94 is below the current price — the current price offers an unfavorable risk-reward ratio; avoid chasing. Strategy: no directional position; existing holders may hold and gradually realize above RMB 13.3 (upper bound of base-case fair value), or wait for catalyst confirmation before re-rating; triggers for potential bullish re-evaluation are a share price falling below RMB 12 (PB ex-perpetuals ≤0.9x) combined with signs of turnover stabilization.
Risk Warnings (Downside): ① Accelerating turnover decline (ADT below RMB 1.5 trillion / margin balance below RMB 2 trillion) → bear case RMB 10.0–11.3; ② Q3 report (10-30) single quarter significantly below RMB 717 million (the cumulative +10% line) → consensus downward revision, valuation reverting to the base-case center; ③ Jington-related court ruling exceeding expectations (range RMB 40–230 million — financially manageable but impacting the classification rating and investment banking pipeline); ④ Structural deterioration of LCR/NSFR (warning lines 135%/140%); ⑤ Huijin-group consolidation explicitly excluding Everbright → impairment of the growth option. Upside Risks (the flip side for shorts/holders of a wait-and-see stance): turnover returning above RMB 3 trillion, Huijin-group consolidation announcements involving Everbright, the appointment of a strongly market-oriented new president — any one of these materializing could push the price toward the bull case of RMB 15.3–18.0; this is the core rationale for an avoid (rather than short) stance.
Tracking Calendar:
Core reconciliation anchors (to verify at the next earnings disclosure): this report's FY2026E net profit attributable RMB 4.1–4.4 billion, revenue RMB 11.4–11.8 billion; Q3 single-quarter three-tier thresholds — breakeven YoY at RMB 449 million / cumulative +10% requires RMB 717 million / YoY positive requires RMB 995 million; whether investment banking single-quarter revenue can bottom out on the RMB 270 million half-year base; whether margin financing market share can hold at 2.0%.
Data and methodology notes: price and valuation percentiles are as of the 2026-10-28 close; financial data as of 2026H1 (the 2026 Q3 report was disclosed on 10-30; this report was completed two days prior); peer PB/ROE are rough estimates compiled from media and research reports, noted as such; total share capital 4.6108 billion shares (A 3.907 + H 0.704), market cap simply summed at A=H price; dual PB calibers (including/excluding RMB 13 billion perpetual bonds) are applied consistently throughout. This report does not constitute investment advice.